Literature DB >> 33655940

Association of chronic rhinosinusitis with bronchial asthma and its severity: A protocol for systematic review and meta-analysis.

Yangwang Pan1, Hongrui Zang.   

Abstract

BACKGROUND: To explore the association of chronic rhinosinusitis (CRS) with bronchial asthma (BA) as well as its severity.
METHODS: A comprehensive database search will be performed from PubMed, Embase, Cochrane Library, and Web of science for related literatures. Heterogeneity test will be used to assess each outcome indicator. If heterogeneity statistics I2 ≥ 50%, the random effects model will be applied; if I2 < 50%, the fixed effects model will be performed. Sensitivity analysis will be performed in all models. STATA 15.0 software (Stata Corporation, College Station, TX) will be used for statistical analysis. Risk ratio (RR) will be used as the effect size for enumeration data. P < .05 is considered statistically significant.
CONCLUSION: This study will evaluate the association of CRS with the prevalence of BA as well as its severity. OSF REGISTRATION NUMBER: 10.17605/OSF.IO/GCTM9.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33655940      PMCID: PMC7939213          DOI: 10.1097/MD.0000000000024772

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  23 in total

Review 1.  Comorbidities of asthma and the unified airway.

Authors:  Robert J Stachler
Journal:  Int Forum Allergy Rhinol       Date:  2015-09       Impact factor: 3.858

2.  Mortality risk in patients with chronic rhinosinusitis and its association to asthma.

Authors:  Jeremiah A Alt; Andrew J Thomas; Karen Curtin; Jathine Wong; Luke Rudmik; Richard R Orlandi
Journal:  Int Forum Allergy Rhinol       Date:  2017-03-08       Impact factor: 3.858

Review 3.  Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.

Authors:  T R Tay; M Hew
Journal:  Allergy       Date:  2017-12-15       Impact factor: 13.146

Review 4.  Is rhinosinusitis a cause of asthma?

Authors:  Brian A Smart
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 5.  Rhinosinusitis and asthma: the missing link.

Authors:  Anne E Dixon
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

6.  Chronic rhinosinusitis in asthma is a negative predictor of quality of life: results from the Swedish GA(2)LEN survey.

Authors:  A Ek; R J M Middelveld; H Bertilsson; A Bjerg; L Ekerljung; A Malinovschi; P Stjärne; K Larsson; S E Dahlén; C Janson
Journal:  Allergy       Date:  2013-09-21       Impact factor: 13.146

7.  Treatment of chronic rhinosinusitis and its effects on asthma.

Authors:  S Ragab; G K Scadding; V J Lund; H Saleh
Journal:  Eur Respir J       Date:  2006-03-01       Impact factor: 16.671

8.  Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care.

Authors:  Aimee Liou; Jessica R Grubb; Kenneth B Schechtman; Daniel L Hamilos
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

Review 9.  The Nose and the Lung: United Airway Disease?

Authors:  Amelia Licari; Riccardo Castagnoli; Chiara Francesca Denicolò; Linda Rossini; Alessia Marseglia; Gian Luigi Marseglia
Journal:  Front Pediatr       Date:  2017-03-03       Impact factor: 3.418

10.  The prevalence of asthma in adult population of southwestern Iran and its association with chronic rhinosinusitis: a GA2LEN study.

Authors:  Afshin Ostovar; Wytske J Fokkens; Safoora Pordel; Ali Movahed; Khadijeh Ghasemi; Maryam Marzban; Shokrollah Farrokhi
Journal:  Clin Transl Allergy       Date:  2019-08-30       Impact factor: 5.871

View more
  1 in total

1.  Association between chronic rhinosinusitis and pneumonia: a longitudinal follow-up study using a national health screening cohort.

Authors:  Jee Hye Wee; Chanyang Min; Hahn Jin Jung; Min Woo Park; Bumjung Park; Hyo Geun Choi
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.